JPH0798808B2 - Novel dimethoxybenzal hydantoin derivative - Google Patents

Novel dimethoxybenzal hydantoin derivative

Info

Publication number
JPH0798808B2
JPH0798808B2 JP61246308A JP24630886A JPH0798808B2 JP H0798808 B2 JPH0798808 B2 JP H0798808B2 JP 61246308 A JP61246308 A JP 61246308A JP 24630886 A JP24630886 A JP 24630886A JP H0798808 B2 JPH0798808 B2 JP H0798808B2
Authority
JP
Japan
Prior art keywords
acid
dimethoxybenzal
novel
dioxo
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61246308A
Other languages
Japanese (ja)
Other versions
JPS63101371A (en
Inventor
亨 小林
毅 三芳
英暉 川島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP61246308A priority Critical patent/JPH0798808B2/en
Priority to US07/038,364 priority patent/US4797493A/en
Priority to DE19873713094 priority patent/DE3713094A1/en
Priority to FR878705711A priority patent/FR2597476B1/en
Priority to KR1019870006755A priority patent/KR900002058B1/en
Publication of JPS63101371A publication Critical patent/JPS63101371A/en
Priority to US07/242,166 priority patent/US5000945A/en
Priority to US07/259,257 priority patent/US4985237A/en
Priority to US07/509,765 priority patent/US5087729A/en
Publication of JPH0798808B2 publication Critical patent/JPH0798808B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/12Face or body powders for grooming, adorning or absorbing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Description

【発明の詳細な説明】 産業上の利用分野 本発明の化合物は、紫外線吸収剤として用いることがで
き、日焼け止め、シミ、ソバカス防止などに有効であ
り、化粧品分野に対し適応できる。
DETAILED DESCRIPTION OF THE INVENTION Industrial Field The compound of the present invention can be used as an ultraviolet absorber, is effective in preventing sunscreen, spots, freckles and the like, and can be applied to the cosmetic field.

従来の技術 紫外線は、皮膚に対して種々の変化をもたらすことが知
られている。皮膚科学では、紫外線を長波長紫外線(40
0〜320nm)、中波長紫外線(320〜290nm)、短波長紫外
線に分け、各々UV−A,UV−B,UV−Cと呼んでいる。これ
らのうち、UV−Cは、オゾン層で吸収され、殆ど地上に
は、達しない。また、UV−Bはその一定量以上が、皮膚
に照射されると、紅斑や、水泡を形成したり、色素沈着
を起こすことが知られている。これに対し、UV−Aは、
従来皮膚に対し、あまり大きな変化を生じさせないと言
われてきた。しかし、最近電子顕微鏡や、組織科学的評
価からUV−Aが、血管壁や結合組織中の弾性繊維に変化
をもたらすことがわかってきた。更に、過敏な皮膚や、
絶えず太陽光線照射に曝されている皮膚に損傷を生じさ
せる。また、UV−AはUV−Bの作用を助長するという報
告もなされており(J.Willis,A.Kligman,and J.Epstein
“Photo-enhancement"The Journal of Investigative D
ermatology 59巻 6号 416頁 1973)、UV−Aを遮蔽
することは、重要である。
2. Description of the Related Art Ultraviolet rays are known to cause various changes in skin. In dermatology, ultraviolet rays are
0-320 nm), medium-wavelength ultraviolet light (320-290 nm), and short-wavelength ultraviolet light, which are called UV-A, UV-B, and UV-C, respectively. Of these, UV-C is absorbed in the ozone layer and hardly reaches the ground. Further, it is known that when a certain amount or more of UV-B is irradiated on the skin, erythema, blisters are formed, and pigmentation is caused. On the other hand, UV-A
Conventionally, it has been said that it does not cause much change to the skin. However, recently it has been found from electron microscopy and histological evaluation that UV-A causes changes in elastic fibers in the blood vessel wall and connective tissue. In addition, sensitive skin,
Causes damage to the skin which is constantly exposed to sunlight. It has also been reported that UV-A promotes the action of UV-B (J. Willis, A. Kligman, and J. Epstein.
“Photo-enhancement” The Journal of Investigative D
ermatology 59 Vol. 6, No. 6, 416, 1973), it is important to block UV-A.

UV−Bにたいしては、これまでベンゾフェノン系紫外線
吸収剤 パラアミノ安息香酸系紫外線吸収剤、ケイ皮酸
系紫外線吸収剤 サリチル酸系紫外線吸収剤等、多くが
開発されてきた。しかし、UV−Aに関する研究の歴史は
浅く、皮膚に適用した場合、効果的にUV−Aを吸収する
物質はあまり知られていない。現在僅かに、ジベンゾイ
ルメタン誘導体、桂皮酸誘導体およびカルコン誘導体が
知られているに過ぎない。(西独特許公開第2728241
号、同2728243号、特開昭51-61641号、同52-46056号、
同57-59840号、同57-197209号、同60-109544号) 本発明が解決しようとする問題点 紫外線吸収能、安全性、溶剤や樹脂への溶解性、および
安定性を兼備したUV−A紫外線吸収剤が望まれている。
For UV-B, many have been developed so far, such as benzophenone-based UV absorbers, para-aminobenzoic acid-based UV absorbers, cinnamic acid-based UV absorbers, and salicylic acid-based UV absorbers. However, the history of research on UV-A is short, and there are few known substances that effectively absorb UV-A when applied to the skin. Currently, only a few dibenzoylmethane derivatives, cinnamic acid derivatives and chalcone derivatives are known. (West German Patent Publication No. 2728241
No. 2,728,243, JP-A-51-61641, JP-A-52-46056,
No. 57-59840, No. 57-197209, No. 60-109544) Problems to be solved by the present invention UV-absorbing ability, safety, solubility in solvent or resin, and stability UV- A UV absorber is desired.

問題点を解決するための手段 本発明者らは、かかる実情を鑑み、鋭意研究を行なった
結果、下記一般式(I)で表わされる新規ジメトキシベ
ンザールヒダントイン誘導体が表1に示すように長波長
紫外線領域(320〜400nm)に大きな吸収効果を有し、更
に各種動植物油、油脂、および、有機溶剤に易溶である
ことから、これら新規ジメトキシベンザールヒダントイ
ン誘導体がUV−Aに対し有効な紫外線吸収剤であること
を見いだし、本発明を完成した。
Means for Solving Problems As a result of intensive studies in view of such circumstances, the present inventors have found that a novel dimethoxybenzal hydantoin derivative represented by the following general formula (I) has a long wavelength as shown in Table 1. These novel dimethoxybenzal hydantoin derivatives have a great absorption effect in the ultraviolet region (320 to 400 nm) and are easily soluble in various animal and vegetable oils, fats and organic solvents. They have found that it is an absorbent and have completed the present invention.

(但し、式1中、Xは水素原子又は-CH2-CH2CO2Rであ
る。Rは炭素数1〜18のアルキル基、シクロヘキシル基
又はトリメチルシクロヘキシル基である。) 本発明に係る一般式(1)表示のジメトキシベンザール
ヒダントイン誘導体は、全て新規化合物であるが、これ
らは既知の方法により製造することができる。すなわ
ち、ジメトキシベンズアルデヒドと、ヒダントインの
塩基触媒による縮合、生成したジメトキシベンザール
ヒダントインに、アクリル酸エステルをマイケル付加し
て、得られる(式1) (但し、式1中、Xは水素原子又は-CH2-CH2CO2Rであ
る。Rは炭素数1〜18のアルキル基、シクロヘキシル基
又はトリメチルシクロヘキシル基である。) 本発明の一般式(1)表示の化合物を例示するならば、
4−(3、4−ジメトキシフェニル)メチレン−2、5
−ジオキソ−1、3−イミダゾリジンジプロピオン酸ジ
メチルエステル、4−(3、4−ジメトキシフェニル)
メチレン−2、5−ジオキソ−1、3−イミダゾリジン
ジプロピン酸ジエチルエステル、4−(3、4−ジメト
キシフェニル)メチレン−2、5−ジオキソ−1、3−
イミダゾリジンジプロピオン酸ジイソプロピルエステ
ル、4−(3、4−ジメトキシフェニル)メチレン−
2、5−ジオキソ−1、3−イミダゾリジンジプロピオ
ン酸 ジn−ブチルエステル、4−(3、4−ジメトキ
シフェニル)メチレン−2、5−ジオキソ−1、3−イ
ミダゾリジンジプロピオン酸ジイソブチルエステル、4
−(3、4−ジメトキシフェニル)メチレン−2、5−
ジオキソ−1、3−イミダゾリジンジプロピオン酸ビス
(2−エチルヘキシルエステル)、4−(3、4−ジメ
トキシフェニル)メチレン−2、5−ジオキソ−1−イ
ミダゾリジンプロピオン酸イソプロピルエステル、4−
(3、4−ジメトキシフェニル)メチレン−2、5−ジ
オキソ−1−イミダゾリジンプロピオン酸メチルエステ
ル、4−(3、4−ジメトキシフェニル)メチレン−
2、5−ジオキソ−1−イミダゾリジンプロピオン酸エ
チルエステル、4−(3、4−ジメトキシフェニル)メ
チレン−2、5−ジオキソ−1−イミダゾリジンプロピ
オン酸 n−ブチルエステル、4−(3、4−ジメトキ
シフェニル)メチレン−2、5−ジオキソ−1−イミダ
ゾリジンプロピオン酸 イソブチルエステル、4−
(3、4−ジメトキシフェニル)メチレン−2、5−ジ
オキソ−1−イミダゾリジンプロピオン酸2−エチルヘ
キシルエステル等が挙げられる。
(However, in Formula 1, X is a hydrogen atom or —CH 2 —CH 2 CO 2 R. R is an alkyl group having 1 to 18 carbon atoms, a cyclohexyl group, or a trimethylcyclohexyl group.) General according to the present invention The dimethoxybenzal hydantoin derivatives represented by the formula (1) are all novel compounds, but they can be produced by a known method. That is, it is obtained by Michael-adding an acrylate ester to dimethoxybenzal hydantoin produced by condensation of dimethoxybenzaldehyde and hydantoin by a base catalyst (formula 1). (However, in Formula 1, X is a hydrogen atom or —CH 2 —CH 2 CO 2 R. R is an alkyl group having 1 to 18 carbon atoms, a cyclohexyl group, or a trimethylcyclohexyl group.) The general formula of the present invention (1) To exemplify the indicated compounds,
4- (3,4-dimethoxyphenyl) methylene-2,5
-Dioxo-1,3-imidazolidine dipropionic acid dimethyl ester, 4- (3,4-dimethoxyphenyl)
Methylene-2,5-dioxo-1,3-imidazolidine dipropynoic acid diethyl ester, 4- (3,4-dimethoxyphenyl) methylene-2,5-dioxo-1,3-
Imidazolidine dipropionic acid diisopropyl ester, 4- (3,4-dimethoxyphenyl) methylene-
2,5-Dioxo-1,3-imidazolidine dipropionic acid di-n-butyl ester, 4- (3,4-dimethoxyphenyl) methylene-2,5-dioxo-1,3-imidazolidine dipropionic acid diisobutyl ester Four
-(3,4-dimethoxyphenyl) methylene-2,5-
Dioxo-1,3-imidazolidinedipropionic acid bis (2-ethylhexyl ester), 4- (3,4-dimethoxyphenyl) methylene-2,5-dioxo-1-imidazolidinepropionic acid isopropyl ester, 4-
(3,4-dimethoxyphenyl) methylene-2,5-dioxo-1-imidazolidinepropionic acid methyl ester, 4- (3,4-dimethoxyphenyl) methylene-
2,5-Dioxo-1-imidazolidinepropionic acid ethyl ester, 4- (3,4-dimethoxyphenyl) methylene-2,5-dioxo-1-imidazolidinepropionic acid n-butyl ester, 4- (3,4 -Dimethoxyphenyl) methylene-2,5-dioxo-1-imidazolidinepropionic acid isobutyl ester, 4-
(3,4-dimethoxyphenyl) methylene-2,5-dioxo-1-imidazolidinepropionic acid 2-ethylhexyl ester and the like can be mentioned.

発明の効果 本発明に用いられる前記一般式(1)表示の新規ジメト
シキベンザールヒダントイン誘導体は、表1に示すよう
に、320〜400nmで104以上の高い分子吸収係数を有す
る。また、これら新規ジメトキシベンザールヒダントイ
ン誘導体は、分子中のRの効果により、既存の化合物、
例えば5−(3、4−ジメトキシフェニル)メチレンヒ
ダントイン等に、比べ各種動植物油、油脂、および有機
溶剤に対する溶解性が、著しく向上した。
EFFECTS OF THE INVENTION The novel dimethoxybenzal hydantoin derivative represented by the general formula (1) used in the present invention has a high molecular absorption coefficient of 10 4 or more at 320 to 400 nm as shown in Table 1. In addition, these novel dimethoxybenzal hydantoin derivatives are the existing compounds due to the effect of R in the molecule.
For example, compared with 5- (3,4-dimethoxyphenyl) methylenehydantoin and the like, the solubility in various animal and vegetable oils, oils and fats, and organic solvents was significantly improved.

このため、前記一般式(1)表示の新規ジメトキシベン
ザールヒダントイン誘導体を、常法により、化粧料用基
剤に配合し、クリーム、溶液、油剤、スプレー、スティ
ック、乳液、ファンデーション、軟膏などの基型の、有
効なUV−A吸収剤を調製できる。
Therefore, the novel dimethoxybenzal hydantoin derivative represented by the general formula (1) is added to a cosmetic base by a conventional method to prepare a base such as cream, solution, oil, spray, stick, emulsion, foundation, ointment. A type of effective UV-A absorber can be prepared.

即ち、本発明化合物を軟膏基剤やクリーム基剤と混合す
ることにより(乳化剤を加えてもよい)日焼け防止用の
オイル、ローションまたはスキンケアー剤を製造するこ
とが出来る。この際、適用される。基剤としては、個体
状或は液状パラフィン、クリスタルオイル、セレシン、
オゾケライトまたはモンタンろう等の炭化水素類;オリ
ーブ、地ろう、カルナバろう、ラノリンまたは鯨ろうな
どの植物油もしくは動物性油脂やろう;ステアリン酸、
パルミチン酸、オレイン酸、イソプロピルミリスチン酸
エステル、等の脂肪酸またはそのエステル類;エチルア
ルコール、イソプロピルアルコール、セチルアルコー
ル、ステアリルアルコール、パルミチルアルコール等の
アルコール類が挙げられる。また、グリセリンまたはソ
ルビトール等の保湿作用を有する多価アルコール類も使
用することが出来る。
That is, by mixing the compound of the present invention with an ointment base or cream base (an emulsifier may be added), a sunscreen oil, lotion or skin care agent can be produced. At this time, it is applied. As a base, solid or liquid paraffin, crystal oil, ceresin,
Hydrocarbons such as ozokerite or montan wax; vegetable or animal oils and waxes such as olive, ground wax, carnauba wax, lanolin or whale wax; stearic acid,
Fatty acids such as palmitic acid, oleic acid, and isopropyl myristate ester, or esters thereof; alcohols such as ethyl alcohol, isopropyl alcohol, cetyl alcohol, stearyl alcohol, and palmityl alcohol. Further, polyhydric alcohols having a moisturizing action such as glycerin or sorbitol can also be used.

本発明のジメトキシベンザールヒダントイン誘導体の配
合量は、一般には組成物ちゅう0.1〜20重量%、好まし
くは0.5〜10重量%配合するのがよい。
The content of the dimethoxybenzal hydantoin derivative of the present invention is generally 0.1 to 20% by weight, preferably 0.5 to 10% by weight of the composition.

また、本発明の新規ジメトキシベンザールヒダントイン
誘導体は、更に、他の紫外線吸収剤と共に配合し、日焼
け止め化粧料として使用することが出来る。これに適し
た紫外線吸収剤としては、例えば、p−メチルベンジリ
デン−D,L−ショウノウまたはそのスルホン酸ナトリウ
ム塩、2−フェニルベンズイミダゾール−5−スルホン
酸ナトリウム塩、3、4−ジメチルフェニルグリオキシ
ル酸ナトリウム塩、4−フェニルベンゾフェノン、4−
フェニルベンゾフェノン−2−カルボン酸イソオクチル
エステル,p−メトキシ桂皮酸エステル、2−フェニル−
5−メチルベンズオキサゾールまたはp−ジメチルアミ
ノ安息香酸エステル類等が挙げられる。
Further, the novel dimethoxybenzal hydantoin derivative of the present invention can be further blended with other ultraviolet absorbers and used as a sunscreen cosmetic. Suitable ultraviolet absorbers include, for example, p-methylbenzylidene-D, L-camphor or its sulfonic acid sodium salt, 2-phenylbenzimidazole-5-sulfonic acid sodium salt, 3,4-dimethylphenylglyoxylic acid. Sodium salt, 4-phenylbenzophenone, 4-
Phenylbenzophenone-2-carboxylic acid isooctyl ester, p-methoxycinnamic acid ester, 2-phenyl-
Examples thereof include 5-methylbenzoxazole and p-dimethylaminobenzoic acid esters.

更に本発明の新規ジメチルベンザールヒダントイン誘導
体配合の化粧料には、種々の添加剤、例えばw/o型およ
びo/w型の乳化剤などを加えることが出来る。
Further, various additives such as w / o type and o / w type emulsifiers can be added to the cosmetic composition containing the novel dimethylbenzalhydantoin derivative of the present invention.

次に、本発明に係る代表的な化合物について、最大吸収
波長ならびに、その他の物性価を実施例1としてまとめ
て表1に示す。また実施例2に代表的な製法を示すが、
本発明はこれらの実施例によって限定されるものではな
い。
Next, the maximum absorption wavelength and other physical properties of the representative compounds according to the present invention are summarized in Table 1 and shown in Table 1. A typical manufacturing method is shown in Example 2,
The invention is not limited by these examples.

実施例1 実施例2 合成例1 4−(3、4−ジメトキシフェニルメチレン)−2、5
−ジオキソ−1−イミダゾリジンプロピオン酸 n−ブ
チルエステルの合成 ジメチルホルムアミド150mlに、5−(3、4−ジメト
キシベンジリデン)ヒダントイン20g(80.6mmol)、ア
クリル酸n−ブチルエステル12.4g(96mmol)および水
酸化カリウム0.90g(1.6mmol)を加え、110℃で2時
間、攪拌した。冷却後、反応液に、水200mlをくわえ、
酢酸エチル500mlで抽出した。抽出液を、硫酸ナトリウ
ムで乾燥した後、溶媒を減圧留去した。トリエンを加
え、析出した結晶を、乾燥し、4−(3、4−ジメトキ
シフェニルメチレン)−2、5−ジオキソ−1−イミダ
ゾリジンプロピオン酸 n−ブチルエステル24.7g(81.
5%)を得た。
Example 1 Example 2 Synthesis Example 1 4- (3,4-dimethoxyphenylmethylene) -2,5
-Synthesis of dioxo-1-imidazolidinepropionic acid n-butyl ester To 150 ml of dimethylformamide, 20 g (80.6 mmol) of 5- (3,4-dimethoxybenzylidene) hydantoin, 12.4 g (96 mmol) of acrylic acid n-butyl ester and water. 0.90 g (1.6 mmol) of potassium oxide was added, and the mixture was stirred at 110 ° C for 2 hours. After cooling, add 200 ml of water to the reaction mixture,
It was extracted with 500 ml of ethyl acetate. After the extract was dried over sodium sulfate, the solvent was distilled off under reduced pressure. Triene was added, and the precipitated crystals were dried, and 4- (3,4-dimethoxyphenylmethylene) -2,5-dioxo-1-imidazolidinepropionic acid n-butyl ester 24.7 g (81.
5%).

合成例2 4−(3、4−ジメトキシフェニルメチレン)−2、5
−ジオキソ−1−イミダゾリジンプロピオン酸 2−エ
チルヘキシルエステルの合成 ジメチルホルムアミド150mlに、5−(3、4−ジメト
キシベンジリデン)ヒダントイン20g(80.6mmol)、ア
クリル酸2−エチルヘキシル17.8g(96mmol)および水
酸化カリウム0.90g(1.6mmol)を加え、110℃で2時
間、攪拌した。冷却後、反応液に、水200mlをくわえ、
酢酸エチル500mlで抽出した。抽出液を、硫酸ナトリウ
ムで乾燥した後、溶媒を減圧留去した。残さを、トルエ
ン−n−ヘキサン(1:1)で再結晶し、析出した結晶
を、乾燥し、4−(3、4−ジメトキシフェニルメチレ
ン)−2、5−ジオキソ−1−イミダゾリジンプロピオ
ン酸 2−エチルヘキシルエステル27.1g(77.8%)を
得た。合成例3 4−(3、4−ジメトキシフェニルメチレン)−2、5
−ジオキソ−1、3−イミダゾリジンプロピオン酸 ジ
エチルエステルの合成 ジメチルホルムアミド150mlに、5−(3、4−ジメト
キシベンジリデン)ヒダントイン20g(80.6mmol)、ア
クリル酸エチル17.7g(177mmol)および水酸化カリウム
0.90g(1.6mmol)を加え、110℃で2時間、攪拌した。
冷却後、反応液に、水200mlをくわえ、酢酸エチル500ml
で抽出した。抽出液を、硫酸ナトリウムで乾燥した後、
溶媒を減圧留去した。残さを、シリカゲルカラムクロマ
トガラフィー(溶離液 トルエン:酢酸エチル=3:1)
で分離精製し、4−(3、4−ジメトキシフェニルメチ
レン)−2、5−ジオキソ−1、3−イミダゾリジンプ
ロピオン酸 ジエチルエステル22.5g(62.3%)を得
た。
Synthesis Example 2 4- (3,4-dimethoxyphenylmethylene) -2,5
Synthesis of 2-dioxo-1-imidazolidinepropionic acid 2-ethylhexyl ester To 150 ml of dimethylformamide, 20 g (80.6 mmol) of 5- (3,4-dimethoxybenzylidene) hydantoin, 17.8 g (96 mmol) of 2-ethylhexyl acrylate and hydroxylation were added. 0.90 g (1.6 mmol) of potassium was added, and the mixture was stirred at 110 ° C for 2 hours. After cooling, add 200 ml of water to the reaction mixture,
It was extracted with 500 ml of ethyl acetate. After the extract was dried over sodium sulfate, the solvent was distilled off under reduced pressure. The residue was recrystallized from toluene-n-hexane (1: 1), and the precipitated crystals were dried and then 4- (3,4-dimethoxyphenylmethylene) -2,5-dioxo-1-imidazolidinepropionic acid. 27.1 g (77.8%) of 2-ethylhexyl ester was obtained. Synthesis Example 3 4- (3,4-dimethoxyphenylmethylene) -2,5
-Synthesis of dioxo-1,3-imidazolidinepropionic acid diethyl ester To 150 ml of dimethylformamide, 20 g (80.6 mmol) of 5- (3,4-dimethoxybenzylidene) hydantoin, 17.7 g (177 mmol) of ethyl acrylate and potassium hydroxide were added.
0.90 g (1.6 mmol) was added, and the mixture was stirred at 110 ° C for 2 hours.
After cooling, add 200 ml of water to the reaction mixture and add 500 ml of ethyl acetate.
It was extracted with. After drying the extract with sodium sulfate,
The solvent was distilled off under reduced pressure. The residue is subjected to silica gel column chromatography (eluent: toluene: ethyl acetate = 3: 1).
The product was separated and purified with 4 to give 4- (3,4-dimethoxyphenylmethylene) -2,5-dioxo-1,3-imidazolidinepropionic acid diethyl ester 22.5 g (62.3%).

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】下記一般式(1)で表わされる新規ジメト
キシベンザールヒダントイン誘導体。 (但し、式1中、Xは水素原子又は-CH2-CH2CO2Rであ
る。Rは炭素数1〜18のアルキル基、シクロヘキシル基
又はトリメチルシクロヘキシル基である。)
1. A novel dimethoxybenzal hydantoin derivative represented by the following general formula (1). (However, in the formula 1, X is a hydrogen atom or —CH 2 —CH 2 CO 2 R. R is an alkyl group having 1 to 18 carbon atoms, a cyclohexyl group or a trimethylcyclohexyl group.)
JP61246308A 1986-04-22 1986-10-16 Novel dimethoxybenzal hydantoin derivative Expired - Lifetime JPH0798808B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP61246308A JPH0798808B2 (en) 1986-10-16 1986-10-16 Novel dimethoxybenzal hydantoin derivative
US07/038,364 US4797493A (en) 1986-04-22 1987-04-14 Benzylidene compounds
DE19873713094 DE3713094A1 (en) 1986-04-22 1987-04-16 BENZYLIDE COMPOUNDS AND THEIR CONTAINING COSMETIC PREPARATIONS AND ULTRAVIOLET ABSORBERS
FR878705711A FR2597476B1 (en) 1986-04-22 1987-04-22 BENZYLIDENIC COMPOUNDS, COMPOSITIONS CONTAINING THE SAME, AND ULTRAVIOLET RADIATION ABSORBING AGENTS MADE THEREFROM.
KR1019870006755A KR900002058B1 (en) 1986-10-16 1987-07-01 Bernzylidene compounds cosmetic compositions containing the same and ultraviolet absorber comprising the same
US07/242,166 US5000945A (en) 1986-04-22 1988-09-08 Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
US07/259,257 US4985237A (en) 1986-04-22 1988-10-18 Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same
US07/509,765 US5087729A (en) 1986-04-22 1990-04-17 Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61246308A JPH0798808B2 (en) 1986-10-16 1986-10-16 Novel dimethoxybenzal hydantoin derivative

Publications (2)

Publication Number Publication Date
JPS63101371A JPS63101371A (en) 1988-05-06
JPH0798808B2 true JPH0798808B2 (en) 1995-10-25

Family

ID=17146619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61246308A Expired - Lifetime JPH0798808B2 (en) 1986-04-22 1986-10-16 Novel dimethoxybenzal hydantoin derivative

Country Status (1)

Country Link
JP (1) JPH0798808B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01230559A (en) * 1988-03-11 1989-09-14 Sagami Chem Res Center 5-substituted methylidenehydantoin derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4917266A (en) * 1972-06-02 1974-02-15
DE3023349A1 (en) * 1980-06-21 1982-01-14 Degussa Ag, 6000 Frankfurt METHOD FOR PRODUCING 5-ARYLIDENE HYDANTOINES (C)
JPS6245553A (en) * 1985-08-23 1987-02-27 Nippon Redarii Kk Production of phenylacetic acid derivative

Also Published As

Publication number Publication date
JPS63101371A (en) 1988-05-06

Similar Documents

Publication Publication Date Title
US5783173A (en) Stable sunscreen composition containing dibenzoylmethane derivative, E. G., PARSOL 1789, and C12, C16, C18, branched chain hydroxybenzoate and/or C12, C16, branched chain benzoate stabilizers/solubilizers
US4584190A (en) Novel chalcone derivatives and ultraviolet absorbers comprising the same
US4387089A (en) 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane
US4867964A (en) Cosmetic composition containing hydroxylated chalcone derivatives and its use for protecting the skin and the hair against luminous radiations, new hydroxylated chalcone derivatives employed and process for their preparation
US5000945A (en) Method of stabilizing a UVB absorbing compound, a stabilized UV absorber, and a cosmetic composition containing the same
CA2064930A1 (en) S-triazinic derivatives having benzylidene camphre substituants, their preparation process, filtrating cosmetic compositions containing them and their use to protect the skin and hair against ultra-violet radition
JPS636526B2 (en)
US4985237A (en) Benzylidene compounds, cosmetic compositions containing the same and ultraviolet absorber comprising the same
US5565191A (en) Cosmetic and dermatological compositions for the protection against UV radiation containing stilbene derivatives
JPH04134043A (en) New alpha-benzylidene ketone derivative, ultraviolet absorber and cosmetic containing said absorber
JP3725564B2 (en) Benzylidenequinuclidinones
JP2002047283A (en) New flavonoid and its use in product for cosmetic or dermatological preparation
JPH1067635A (en) Use of alpha-acyl-, beta-allylacylnitrile as ultraviolet-a filter in cosmetic preparation and light-protecting agent containing the compound and new compound of the same kind
US5144081A (en) Dialkoxybenzylidene-camphor derivatives
JPH04134042A (en) Styryl ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber
JPH04290882A (en) Gamma-pyrone derivative and ultraviolet ray absorber and cosmetic containing the same
JPH04134041A (en) P-xylidene ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber
EP0663206B1 (en) Naphthalenmethylenemalonic diesters, and UV absorbers and cosmetic compositions containing the diesters
JPH0798808B2 (en) Novel dimethoxybenzal hydantoin derivative
JPH0635416B2 (en) Benzoyl pinacolone derivative, ultraviolet absorber containing the same, and cosmetics containing the same
JPH07238275A (en) Ultraviolet light absorber and skin external preparation containing the same blended therein
JP2780091B2 (en) Long wavelength UV absorber
JPH11514655A (en) Cosmetic formulations containing light-stable UV-A-filters
JP3345492B2 (en) 2,6-Naphthalenebis (methylenemalonic diester) derivative, ultraviolet absorber and cosmetic containing the same
JPH07330673A (en) Perfluoroalkyl group-bearing benzal malonate derivative, production thereof, and ultraviolet rays absorber and cosmetic containing the same

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term